Prognostic factors in patients with stage II colon cancer: Role of E-selectin gene polymorphisms

Dig Liver Dis. 2019 Aug;51(8):1198-1201. doi: 10.1016/j.dld.2019.05.019. Epub 2019 Jun 18.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy
  • Aged
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy
  • E-Selectin / genetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Polymorphism, Genetic
  • Prognosis
  • Survival Analysis
  • Treatment Outcome

Substances

  • E-Selectin
  • SELE protein, human